RxDoctor Payments Data
★ My doctorsLook up a doctor →

Emilee Bejarano, APRN

Gerontology · North Kansas City, MONPI 1760219901

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations.

$2,634in general payments, 2019–2025

Across 100 payments — averaging $26.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$352
  • Pfizer$239
  • EMD Serono, Inc.$177
  • Eisai Inc.$166
  • Lundbeck LLC$150
  • Axsome Therapeutics, Inc.$144
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$2,58098%
  • Education$542%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie9$352
Pfizer13$239
EMD Serono, Inc.3$177
Eisai Inc.4$166
Lundbeck LLC7$150
Axsome Therapeutics, Inc.2$144
UCB, Inc.6$135
Lilly USA, LLC2$122
Biogen5$97
Acadia Pharmaceuticals Inc5$89
Azurity Pharmaceuticals, Inc.4$78
CSL Behring3$72
ANI Pharmaceuticals, Inc.3$67
Genentech USA, Inc.3$65
Medtronic2$54
Sanofi2$52
Teva Pharmaceuticals USA, Inc.3$52
Argenx US, Inc.2$47
Neurocrine Biosciences, Inc.2$42
Otsuka America Pharmaceutical, Inc.2$37
Scilex Pharmaceuticals Inc.2$37
SK Life Science, Inc.2$36
Xeris Pharmaceuticals, Inc.2$32
Jazz Pharmaceuticals Inc.1$30
Amneal Pharmaceuticals LLC1$28
Aimmune Therapeutics, Inc.1$28
TG Therapeutics, Inc.1$27
Harmony Biosciences LLC1$26
Mallinckrodt Hospital Products Inc.1$26
C2n Diagnostics, LLC1$22
Catalyst Pharmaceuticals, Inc.1$22
Cycle Pharmaceuticals Inc1$22
Takeda Pharmaceuticals U.S.A., Inc.1$21
Merz Pharmaceuticals, LLC1$20
Supernus Pharmaceuticals, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,634 in reported general payments places this provider in the 85th percentile of 175 gerontology providers in Missouri.

See all gerontology providers in Missouri →

Medicare billing

Part B allowed, 2024
$1,380
Medicare patients
14
Services billed
14

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in North Kansas City

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →